BMS-741672

CAS No. 1004757-96-3

BMS-741672( BMS741672 )

Catalog No. M10035 CAS No. 1004757-96-3

BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1863 Get Quote
50MG 3762 Get Quote
100MG 5220 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-741672
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.
  • Description
    BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.Diabetes Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BMS741672
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    Metabolic Disease
  • Indication
    Diabetes

Chemical Information

  • CAS Number
    1004757-96-3
  • Formula Weight
    506.574
  • Molecular Formula
    C25H33F3N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(N[C@H]1[C@@H](N2C([C@@H](NC3=C4C=C(C(F)(F)F)C=CC4=NC=N3)CC2)=O)CC[C@@H](N(C(C)C)C)C1)=O
  • Chemical Name
    N-((lR,2S,5R)-5-(isopropyl(methyl)amino)-2-((S)-2-oxo-3-(6- (trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-l-yl)cyclohexyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Joerg Deerberg, et al. Org. Process Res. Dev., 2016, 20 (11), pp 1949-1966.
molnova catalog
related products
  • GSK812397

    GSK812397 is a potent, selective, noncompetitive, orally available antagonist of CXCR4 receptor.

  • BI 639667

    BI 639667 (BI639667) is a potent and selective antagonist of human CCR1 with binding IC50 of 5.4 nM.

  • AF-399 42016530

    A potent CCR4 antagonist that blocked CCL22- and CCL17-mediated migration of human peripheral blood CD4+CD25+ Treg and Th2 cells ex-vivo and murine Tregs in-vivo.